Previously, NVP-BEZ235 has been shown to suppress the growth of xenografts generated from thyroid cancer cells (Ruan et al., 2020), hepatocellular carcinoma cells (Liu et al., 2019) and HER2-positive gastric cancer cells (Zhu et al., 2015). This evidence concerns the gene ERBB2 and gastric cancer.